Mid-day market update: Crude oil up 1.5%, Seres Therapeutics shares plunge


Midway through trading Thursday, the Dow traded down 0.08% to 34,768.64 while the NASDAQ rose 0.10% to 14,646.39. The S&P also fell, dropping 0.02% to 4,357.70.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 34,229,800 cases with around 609,870 deaths. India confirmed a total of at least 31,257,720 cases and 418,980 deaths, while Brazil reported over 19,473,950 COVID-19 cases with 545,600 deaths. In total, there were at least 192,054,100 cases of COVID-19 worldwide with more than 4,128,050 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Information technology shares climbed 0.6% on Thursday. Meanwhile, top gainers in the sector included ACM Research, Inc. ACMR 3.95%, up 4%, and Veritone, Inc. VERI 4.33%, up 4%.

In trading on Thursday, energy shares fell 1.2%.

Top Headline

AT&T Inc. T 0.29% reported better-than-expected results for its second quarter.

AT&T reported quarterly adjusted earnings of $0.89 per share, beating analysts’ estimates of $0.79 per share. The company’s revenue came in at $44.05 billion, versus expectations of $42.64 billion.

AT&T said it expects FY21 sales growth in the 2-3% range and also projects adjusted EPS to grow in the mid to mid-single digits.

Equities Trading UP

NRx Pharmaceuticals, Inc. NRXP 46.09% shares shot up 45% to $14.69 as the company said it has validated the first commercial formulation of Zyesami for intravenous use, allowing for high volume manufacturing, with an anticipated one year or greater stability under appropriate storage conditions.

Shares of Summit Wireless Technologies, Inc. WISA 32.68% got a boost, shooting 31% to $5.34 after the company highlighted the launch of its Amazon storefront.

ImmunoPrecise Antibodies Ltd. IPA 169.59% shares were also up, gaining 143% to $13.47 after the company announced new results from its TATX-03 PolyTope Therapy, demonstrating potent pseudovirus neutralizing activity against the SARS-CoV-2 Delta (B.1.617.2) variant.

Equities Trading DOWN

Seres Therapeutics, Inc. MCRB 55.6% shares tumbled 55% to $9.40 after the company announced topline results from the Phase 2b ECO-RESET study evaluating SER-287 in patients with mild-to-moderate ulcerative colitis (UC). The study did not meet its primary endpoint of improving clinical remission rates compared to placebo.

Shares of TRACON Pharmaceuticals, Inc. TCON 23.83% were down 24% to $3.7450 after the company announced it increased a previously announced bought deal offering of common stock to $15 million.

Jupiter Wellness, Inc. JUPW 24.38% was down, falling 24% to $2.12 after the company announced pricing of a $32.5 million underwritten public offering of common stock and warrants.

Commodities

In commodity news, oil traded up 1.5% to $71.40, while gold traded up 0.2% to $1,806.60.

Silver traded up 0.6% Thursday to $25.405 while copper rose 1.3% to $4.3275.

Euro zone

European shares were mostly higher today. The eurozone’s STOXX 600 rose 0.56%, the Spanish Ibex Index rose 0.64% and the German DAX 30 gained 0.35%. Meanwhile, the London’s FTSE 100 fell 0.56%, French CAC 40 surged 0.17% and Italy’s FTSE MIB climbed 0.53%.

The European Central Bank announced plans to keep interest rates and asset purchases unchanged. The manufacturing climate indicator in France climbed to 110 in July from a revised reading of 108 in the prior month. The CBI's quarterly gauge of manufacturing optimism for the UK declined to 27 in the third quarter compared to 38 in the prior three-month period.

Economics

US initial jobless claims rose to 419,000 in the latest week, versus a revised reading of 368,000 in the previous week.

The Chicago Fed National Activity Index fell to 0.09 in June from a revised reading of 0.26 in May.

Existing home sales rose 1.4% to 5.86 million in June.

The index of leading economic indicators rose 0.7% for June.

The Kansas City Fed's manufacturing production index surged to a record high of 41 in July versus 30 in the prior month.

Benzinga does not provide investment advice. All rights reserved.

Feed news

Latest Forex Analysis


Latest Forex Analysis

Editors’ Picks

EUR/USD hovers around 1.1900, retains weekly gains

The EUR/USD pair trades around the 1.19 mark after the Eurozone Q2 Prelim GDP beat estimates with 2% while US PCE inflation rose by less than anticipated in June, printing at 3.5% YoY. Risk-on mood persists.

EUR/USD News

GBP/USD retreats after flirting with 1.4000

GBP/USD retreated from near the 1.4000 level, but the greenback remains away from investors' radar. Optimism over the Brexit issue and the declining trend in new COVID-19 cases in the UK offers support to the pound.

GBP/USD News

XAU/USD slides to $1,820 area, downside seems limited

Gold traded with a mild negative bias around the $1,825 region, or daily lows, during the early North American session, albeit lacked any follow-through selling.

Gold News

Shiba gets listed on eToro as demand for SHIB skyrockets

Leading investment platform eToro has been adding cryptocurrency assets on popular demand from users. The Dogecoin killer recently amassed 600,000 holders despite range-bound price action. 

Read more

NIO shares rise again as Wall Street shrugs off recent China woes

NYSE:NIO added 1.86% as EV and China stocks bounced back again. Nio rides higher as industry leader Tesla gets some major upgrades. Nio rival XPeng releases a refreshed look for its compact SUV.

Read more

Majors

Cryptocurrencies

Signatures